LAMICTAL 5 mg, dispersible or chewable tablet 30 tablets
Brand page: Lamictal (lamotrigine) — all forms and strengths in France
Active ingredients: Lamotrigine
Commercialized according to BDPMDispensing in France: Prescription only
Dispersible or chewable tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LAMICTAL 5 mg, comprimé dispersible ou à croquer
- Pharmaceutical form
- comprimé dispersible ou à croquer
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec fermeture de sécurité enfant
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Jul 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68058063CIP73018635CIP133400930186350Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LAMOTRIGINEcomprimé | 5,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.